• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

GlaxoSmithKline plc. (7/12/18). "Press Release: James Ford Appointed GSK General Counsel". London.

	Organisation	GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
	Group	GlaxoSmithKline (GSK) (Group)
	Product	legal services
	Product 2	pharmaceutical

GSK today announced that James Ford, currently SVP and General Counsel for Global Pharma, will succeed Dan Troy as General Counsel, GSK. James will join the Corporate Executive Team (CET) on 1 August.

Through his 23-year career with GSK, James has gained wide-ranging legal experience including investigations, complex corporate transactions and litigation in senior roles across the USA, Asia and UK.

James replaces Dan Troy who will leave GSK after 10 years as General Counsel.


GSK - a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

For further information please visit www.gsk.com/about-us


Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Principal risks and uncertainties' in the company's Annual Report on Form 20-F for 2017.

Record changed: 2018-07-18

Advertisement

More documents for GlaxoSmithKline (GSK) (Group)

• [1] GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London....
• [2] GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London....
• [3] GlaxoSmithKline plc. (1/21/19). "Press Release: GSK Announces Succession Plan to Appoint New Chairman"....
• [4] Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris....
• [5] GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever"....
• [6] GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London....
• [7] GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London....
• [8] GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London....
• [9] Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London....
• [10] Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.